Abstract:Fluoroquinolone (FQ)-resistant Campylobacter jejuni is a serious problem worldwide that limits effective treatment of infections. The traditional detection method depends on bacterial isolation and MIC testing, or traditional PCR, which is time-consuming and hard to identify the FQ-resistant C. jejuni in a high abundance wild-type background. This study aimed to develop a rapid and accurate ddPCR assay to detect FQ-resistant C. jejuni mutants based on the crucial resistance mutation C257T (Thr-86-Ile) in gyrA. Our ddPCR gyrA assay showed high specificity and accuracy. Sanger sequencing and the qPCR assay could only recognize gyrA mutant sequences when the ratios of wild-type/mutant were 1:1 or 10:1, respectively. Our ddPCR gyrA assay was able to detect gyrA mutant sequences in the mixtures with up to at least 1000:1 wild-type/mutant ratios, which suggested a significant advantage to distinguish the low mutant signal from the wild-type background. We further monitored the occurrence of gyrA mutations under ciprofloxacin pressure using our ddPCR gyrA assay, and clearly showed that the transition of a dominant C. jejuni subpopulation from wild-type to gyrA C257T mutant, resulting in FQ-resistance. We tested 52 samples from live chickens and retail chicken meat and showed that four samples contained wild-type/mutant mixtures comprising 1.7%, 28.6%, 53.3%, and 87.0% gyrA C257T mutants, respectively. These results demonstrated that the ddPCR gyrA assay was a highly sensitive alternative method to distinguish and quantify FQ-resistant C. jejuni infections that could help guide the appropriate use of FQs in clinical practice. IMPORTANCE Campylobacter jejuni is considered to be the leading cause of human bacterial gastroenteritis worldwide, and fluoroquinolones (FQs) are the main choices for the treatment of bacterial gastroenteritis in clinical practice. In theory, antimicrobial susceptibility testing should help us to choose the most appropriate drugs for the treatment. However, to test the susceptibility of C. jejuni to FQs, the standardized method is bacteria isolation and MIC measurement, which will take more than 4 days. In addition, a low abundance of FQ-resistant C. jejuni is also hardly distinguished from a high abundance of wild-type background in the mixed infection. Therefore, the development of rapid and accurate detection technology for FQ-resistant C. jejuni is very important. This study provided a ddPCR gyrA assay, which is a highly sensitive alternative method to distinguish and quantify FQ-resistant C. jejuni infections that may help guide the appropriate use of FQs both in veterinary and human clinical practice.

A Fluoroquinolone Resistance Associated Mutation in Gyra Affects DNA Supercoiling in Campylobacter Jejuni.

Emergence of novel variants of DNA gyrase subunit A gyrA gene in drug-resistant Enterobacter aerogenes

On the Resistance of Escherichia Coli Strains Isolated from Healthy People's Intestines to Fluroquinolones and Its Mechanism

Acquisition of fluoroquinolone resistance leads to increased biofilm formation and pathogenicity in Campylobacter jejuni

Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance Inacinetobacter Pittii

A study on GyrA and ParC mutant in fluoroquinolone-resistant clinical isolates of Klebsiella pneumoniae

Correlation Between Gyra and CmeR Box Polymorphism and Fluoroquinolone Resistance in Campylobacter Jejuni Isolates in China

Droplet Digital PCR-Based Detection and Quantification of GyrA Thr-86-Ile Mutation Based Fluoroquinolone-Resistant Campylobacter Jejuni

Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria

Detection and Analysis of gyrA in Fluoroquinolone-Resistant Escherichia coli Isolates Collected from Different Breeding Environments

Characterization of Mutations in Gyra Gene Associated with Fluoroquinolones-Resistant Mycoplasma Gallisepticum Selected in Vitro

Mutant prevention concentrations of fluoroquinolones against Campylobacter jejuni isolated from chicken.

Fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli from poultry and human samples assessed by PCR-restriction fragment length polymorphism assay

Mutations in Gyrase and Topoisomerase Genes Associated with Fluoroquinolone Resistance in Salmonella Serovars from Retail Meats

Gyra/b Fluoroquinolone Resistance Allele Profiles Amongst Mycobacterium Tuberculosis Isolates from Mainland China

Gene Mutation Mechanism of Resistance to Fluoroquinolone in E.coli

[Role of Fliy Gene in Pathogenicity-Associated Chemotaxis and Colonization of Campylobacter Jejuni].

Mutation detection of QRDR of gyrA gene of Escherichia coli derived from chick and resistant fuoroquinolone

gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity1

Genetic and Phenotypic Variation of Campylobacter jejuni NCTC11168 Caused by flhA Mutation during Laboratory Passage

CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.